여성 건강 재활 제품 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 치료법별, 지역별, 부문별 예측(2025-2030년)

Women's Health Rehabilitation Products Market Growth & Trends:

The global women's health rehabilitation products market size is expected to reach USD 7.22 billion by 2030, registering a CAGR of 6.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of chronic diseases coupled with rising female geriatric population.

Growing global population coupled with increasing birth rates is expected to increase consumer base in emerging and underdeveloped economies with large untapped opportunities. In addition, increasing employment of women at a global level results in higher disposable income and this has also resulted in development of chronic conditions due to sedentary lifestyle, stress/fatigue. These factors are further anticipated to push the demand for rehabilitation products over the forecast period.

Use of new technology such as virtual simulation, or wearables, and robotics in rehabilitation devices is gaining popularity worldwide. For instance, the shift from "crutches and mobility helps" to "specific motor function (hand or arm) rehabilitation devices," propels the market demand over the forecast period. Community-based rehabilitation programs were initiated by the WHO to improve quality of the life of people with disabilities to help them meet their basic needs, which is further expected to assist in growth over the forecast period.

Women's Health Rehabilitation Products Market Report Highlights:

• Urinary incontinence segment held a lucrative revenue share in 2024 and is likely to grow at a significant rate during the forecast period
• Orthopedic care segment is anticipated to witness the fastest growth over the forecast period owing to increasing prevalence of osteoporosis and arthritis among females worldwide
• Physical therapy segment is expected to dominate the women's health rehabilitation products market over the forecast period owing to increasing acceptance among women across the world
• North America is expected to dominate the women's health rehabilitation products during the forecast period, owing to increasing demand for rehabilitation and post-treatment care products in the U.S. and Canada. In addition, increasing geriatric population, breast cancer cases, and road accidents in the region are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Therapy
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Women's Health Rehabilitation Products Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Women's Health Rehabilitation Products Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Orthopedic care
  • 4.4.1. Orthopedic care market, 2018 - 2030 (USD Million)
• 4.5. Urinary incontinence
  • 4.5.1. Urinary incontinence market, 2018 - 2030 (USD Million)
• 4.6. Breast cancer care
  • 4.6.1. Breast cancer care market, 2018 - 2030 (USD Million)
• 4.7. Pelvic pain
  • 4.7.1. Pelvic pain market, 2018 - 2030 (USD Million)
• 4.8. Lymphedema
  • 4.8.1. Lymphedema market, 2018 - 2030 (USD Million)
• 4.9. Pregnancy and postpartum care
  • 4.9.1. Pregnancy and postpartum care market, 2018 - 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Other Women's health rehabilitation products market, 2018 - 2030 (USD Million)

Chapter 5. Women's Health Rehabilitation Products Market: Therapy Business Analysis

• 5.1. Therapy Market Share, 2024 & 2030
• 5.2. Therapy Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Therapy , 2018 to 2030 (USD Million)
• 5.4. Physical therapy
  • 5.4.1. Physical therapy market, 2018 - 2030 (USD Million)
• 5.5. Occupational therapy
  • 5.5.1. Occupational therapy market, 2018 - 2030 (USD Million)
• 5.6. Massage therapy
  • 5.6.1. Massage therapy market, 2018 - 2030 (USD Million)
• 5.7. Chiropractic therapy
  • 5.7.1. Chiropractic therapy market, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Other therapy market, 2018 - 2030 (USD Million)

Chapter 6. Women's Health Rehabilitation Products Market: Regional Estimates & Trend Analysis by Product And Therapy

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. U.S. women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. Canada women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. Mexico women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. UK women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. Germany women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. France women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. Italy women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Spain women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Norway women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamic
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive insights
    • 6.5.8.4. Denmark women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key country dynamic
    • 6.5.9.2. Regulatory framework
    • 6.5.9.3. Competitive insights
    • 6.5.9.4. Sweden women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Japan women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. China women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key country dynamic
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive insights
    • 6.6.4.4. India women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamic
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive insights
    • 6.6.5.4. South Korea women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key country dynamic
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive insights
    • 6.6.6.4. Australia women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key country dynamic
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive insights
    • 6.6.7.4. Thailand women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. Brazil women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Argentina women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key country dynamic
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive insights
    • 6.8.2.4. South Africa women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key country dynamic
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive insights
    • 6.8.3.4. Saudi Arabia women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key country dynamic
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive insights
    • 6.8.4.4. UAE women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key country dynamic
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Competitive insights
    • 6.8.5.4. Kuwait women's health rehabilitation products market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. GE HealthCare
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial performance
    • 7.5.1.3. Product benchmarking
    • 7.5.1.4. Strategic initiatives
  • 7.5.2. Access Health
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial performance
    • 7.5.2.3. Product benchmarking
    • 7.5.2.4. Strategic initiatives
  • 7.5.3. GPC Medical Ltd
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial performance
    • 7.5.3.3. Product benchmarking
    • 7.5.3.4. Strategic initiatives
  • 7.5.4. Zynex, Inc
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial performance
    • 7.5.4.3. Product benchmarking
    • 7.5.4.4. Strategic initiatives
  • 7.5.5. Win Health Medical Ltd
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial performance
    • 7.5.5.3. Product benchmarking
    • 7.5.5.4. Strategic initiatives
  • 7.5.6. Meyer Physical Therapy
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial performance
    • 7.5.6.3. Product benchmarking
    • 7.5.6.4. Strategic initiatives
  • 7.5.7. AliMed
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Product benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. DeRoyal Industries, Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Product benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. Essity Medical Solutions
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Product benchmarking
    • 7.5.9.4. Strategic initiatives
  • 7.5.10. Accord Medical Products
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial performance
    • 7.5.10.3. Product benchmarking
    • 7.5.10.4. Strategic initiatives